5-Year Outcomes of a Randomized Prospective Trial of Tacrolimus Maintenance Monotherapy After Alemtuzumab Induction and Early Steroid Withdrawal in Kidney Transplantation: Rejection, HLA Antibody Formation, and Recurrent Disease.
A. McLean
◽
K. Chan
◽
C. Roufosse
◽
T. Cook
◽
P. Brookes
◽
...